Cited 0 times in
The comparison of Carfilzomib, and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.